Myriad Genetics
DC · 20 filings, 2025
What the money shows
Myriad Genetics reported $1.1M in federal lobbying for 2025 across 20 filings. The filings name 5 lobbying firms, led by Blount Strategic Initiatives and TIBER CREEK. The filing text lists 4 issue areas.
Sources: Senate LDA · FEC
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to a particular drug therapy (precision medicine), assess a patient's risk of disease progression and disease recurrence (precision medicine), and measure disease activity. via Wikipedia ↗
1Lobbies on
Its filings list: Medicare/Medicaid · Veterans · Health Issues · Insurance
2Through these firms · 5
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5237A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a comp…
- S 5242A bill to provide for digital communication of prescribing information for drugs (including biological prod…
- HR 10033Rules for self-driving cars and emergency crews